Information Journal Paper
APA:
Copy. (2018). Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1. ONCOTARGET, 9(2), 0-0. SID. https://sid.ir/paper/721934/en
Vancouver:
Copy. Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1. ONCOTARGET[Internet]. 2018;9(2):0-0. Available from: https://sid.ir/paper/721934/en
IEEE:
Copy, “Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1,” ONCOTARGET, vol. 9, no. 2, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/721934/en